RecruitingNAINTERVENTIONAL

Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE)

This study, called BCB CARCINOSE, is looking into a type of cancer known as peritoneal carcinosis. This is when cancer cells are found in the lining of the abdomen. The main aim is to create a collection of information and samples (like blood and tissue) from patients with this condition. By carefully studying these, researchers hope to learn more about how peritoneal carcinosis develops and behaves. This deeper understanding is key to finding more effective and specific treatments. Your participation would help scientists develop new research specifically focused on this cancer, potentially leading to better outcomes for patients in the future.

At a glance

Status

Recruiting

Phase

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle

Enrolment target

600

Start

25 Nov 2019

Estimated completion

01 Feb 2038

Cancer Peritoneal Carcinosis

What is this study about?

Peritoneal carcinosis is a serious condition where cancer has spread to the peritoneum, which is the protective lining inside your abdomen that covers many of your internal organs. Understanding how this type of cancer works is really important for doctors and scientists to be able to treat it effectively.

At the moment, our understanding of peritoneal carcinosis is still developing. That's why this study aims to create a special collection, or 'database', of information and biological samples from patients who have this condition. These samples might include things like small amounts of blood or tissue that are already being collected as part of your normal care.

The main goal of gathering all this information and these samples is to help researchers learn more about how peritoneal carcinosis grows and spreads. With a better understanding of these processes, scientists can then work on developing new, more targeted treatments that are specifically designed for this type of cancer. This research is about paving the way for better care in the future.

Key takeaways

Aims to understand peritoneal carcinosis better.
Collects biological samples (blood, tissue) and medical data.
Goal is to develop new and specific treatments.
No new treatments or procedures involved.
Helps scientists to advance cancer research.
You can stop participating at any time.

Who may be eligible?

To take part in this study, you need to be an adult over 18 years old. You must have been diagnosed with peritoneal carcinosis, which could have started from different places like the stomach, bowel, or pancreas, or directly in the peritoneum itself. You should also be planning to have treatment for your peritoneal carcinosis, such as surgery or chemotherapy, or other recognised treatments for this condition.

Crucially, you must be happy to agree to all the study procedures, including providing biological samples (like blood) and tissue samples, and you need to give your informed consent, which means you understand what's involved and agree to take part voluntarily.

There are a few reasons why someone might not be able to join. For example, if you are pregnant or breastfeeding, you would not be able to participate. Also, if you are unable to understand the study information or follow instructions, or if you are under guardianship, you wouldn't be eligible. It's also important to be part of the social security system.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 or older?
Have you been diagnosed with peritoneal carcinosis?
Are you receiving treatment for peritoneal carcinosis (e.g., surgery, chemotherapy)?
Are you able to understand the study and agree to share samples and information?
Are you not pregnant or breastfeeding?
Are you affiliated with the Social Protection system?

Answer every question to see your result.

What does participation involve?

If you decide to take part, your involvement will mainly include allowing researchers to collect biological samples, such as blood and tissue. These samples will typically be taken during procedures you are already having as part of your standard medical care for peritoneal carcinosis. There won't be any extra visits solely for the study; instead, information and samples will be collected during your existing appointments or treatments. The study aims to gather data over time, so your medical information and samples would be added to the collection as your treatment progresses. The full duration of your participation would depend on your ongoing treatment and follow-up.

Potential risks and benefits

The main benefit of taking part is that you would be contributing to vital research that could lead to a better understanding and new treatments for peritoneal carcinosis, helping future patients. This study doesn't involve new treatments or procedures, so the risks are generally very low; they would be the usual risks associated with routine blood tests or tissue collection you would undergo anyway. You are free to withdraw from the study at any time without affecting your medical care.

Locations (1)

Institut du cancer de Montpellier ICM
Verified postcode
Montpellier, France· Recruiting

Common questions

What is peritoneal carcinosis?

It's a type of cancer where cancer cells are found in the lining of the abdomen, called the peritoneum.

Will I receive new treatment in this study?

No, this study focuses on collecting information and samples to understand the cancer better, not on testing new treatments directly.

What kind of samples will be collected?

Researchers will collect biological samples, like blood and tissue, often from procedures you're already having for your care.

Does taking part affect my current medical treatment?

No, your decision to take part or not will not affect the medical care you receive for your condition.

How long will I be involved in the study?

Your involvement is usually linked to your ongoing treatment and follow-up, as samples and information are collected over time.

How to find out more

Aurore MOUSSION

aurore.moussion@icm.unicancer.fr 467613100 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.